中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共241条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Heat sensitive E-helix cut ferritin nanocages for facile and high-efficiency loading of doxorubicin 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 卷号: 253
作者:  Xia, Haining;  Xu, Huangtao;  Wang, Jiarong;  Wang, Changhao;  Chen, Ruiguo;  Tao, Tongxiang;  Xu, Shuai;  Zhang, Jing;  Ma, Kun;  Wang, Junfeng
收藏  |  浏览/下载：26/0  |  提交时间：2023/11/17
Ferritin nanocages  Drug loading  Structural modification  Thermal response  Ion-assisted  
'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective 期刊论文
CHEMICAL SOCIETY REVIEWS, 2023
作者:  Fu, Liyi;  Zhang, Yang;  Farokhzad, Ryan A.;  Mendes, Barbara B.;  Conde, Joao;  Shi, Jinjun
收藏  |  浏览/下载：32/0  |  提交时间：2023/11/17
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy 期刊论文
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13
作者:  Hua, Chen;  Shena, Lijuan;  Zoua, Fengming;  Wua, Yun;  Wanga, Beilei;  Wanga, Aoli;  Wud, Chao;  Wanga, Li;  Liua, Jing;  Wanga, Wenchao;  Liua, Qingsong
收藏  |  浏览/下载：38/0  |  提交时间：2023/11/10
Acquired resistance mutations  CDK9 inhibitors  Transcription  Single nucleotide polymorphisms  BAY1251152  
Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin 期刊论文
MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 卷号: 30
作者:  Zhang, Lin;  Li, Ling;  Wang, Xia;  Liu, Huimin;  Zhang, Yibin;  Xie, Tiantian;  Zhang, Hui;  Li, Xiaodong;  Peng, Tianhuan;  Sun, Xing;  Dai, Jing;  Liu, Jing;  Wu, Wencan;  Ye, Mao;  Tan, Weihong
收藏  |  浏览/下载：47/0  |  提交时间：2022/12/23
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong;  Cai, Ying;  Cui, Dawei;  Wang, Liang;  Chen, Wei;  Wang, Xiang
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/22
gefitinib  CD28H  NSCLC  EGFR mutation  
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi;  Yu, Chang;  Li, Guangliang;  Wang, Xiaojia;  Shao, Xiying
收藏  |  浏览/下载：41/0  |  提交时间：2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)  apatinib  case report  
Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug 期刊论文
CURRENT ONCOLOGY, 2022, 卷号: 29
作者:  Zhang, Xiao-Ling;  Ying, Jie-Er
收藏  |  浏览/下载：39/0  |  提交时间：2022/12/23
olanzapine  CINV  mechanism  dosage  time  routes  
Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma 期刊论文
FRONTIERS IN PUBLIC HEALTH, 2022, 卷号: 10
作者:  Shao, Guoliang;  Wang, Jingwen;  Zhou, Xiaoying;  Sun, Guojun;  Dong, Zuojun
收藏  |  浏览/下载：40/0  |  提交时间：2022/12/23
DEB-TACE  cTACE  partition survival model  cost-effectiveness analysis  hepatocellular carcinoma  
Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Guo-Zhen;  Ma, Li-Ying;  Zhang, Zong-Hui;  Wang, Xiao-Lin;  Hua, Jing-Han;  Zhang, Jia-Hui;  Lv, Yang;  Zhang, Shao-Bo;  Ou, Jian;  Lin, Wen-Chu
收藏  |  浏览/下载：47/0  |  提交时间：2022/12/22
small-cell lung cancer  H3  3  PARP1  PARP inhibitor  darinaparsin  combination treatment  
S3I-201 derivative incorporating naphthoquinone unit as effective STAT3 inhibitors: Design, synthesis and anti-gastric cancer evaluation 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 卷号: 71
作者:  Li, Haobin;  Cai, Maohua;  Cao, Fei;  Yu, Dehua;  Yang, Jing;  Yu, Wenkai;  Chu, Chu;  Guan, Xiaoqing;  Qin, Jiang-Jiang;  Dong, Jinyun
收藏  |  浏览/下载：42/0  |  提交时间：2022/12/22
STAT3 inhibitor  Quinone derivative  S3I-201  Anti -gastric cancer drug